The Carlyle Group Invests in eScreen Inc
Summary
Washington, DC – Global private equity firm The Carlyle Group today announced it has made an investment in eScreen, Inc., a leading provider of instrumented drug screening and electronic hiring program management solutions. eScreen’s services and suite of related offerings include medical review, physicals and integrated pre‐employment program management software. “The company’s unique, proprietary, first‐to‐market products and software deliver results in fifteen minutes or less and automate the hiring process for the employer, the applicant and the clinic. “Carlyle looks forward to working with eScreen to capitalize on opportunities in this large and expanding market,” continued Mr. Grady. eScreen is a proven industry innovator and we look forward to funding new initiatives that will continue to expand our portfolio of cutting‐edge products and services.” Carlyle’s investment comes from Carlyle Venture Partners III, a $605 million U.S. venture and growth capital fund closed in 2007.